← Evidence map

ArticleFrontiers in immunology2024

Development of a recombinant human IgG1 monoclonal antibody against the TRBV5-1 segment of the T cell receptor for the treatment of mature T cell neoplasms.

Michele Pitaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Development of a recombinant human IgG1 monoclonal antibody against the TRBV5-1 segment of the T cell receptor for the treatment of mature T cell neoplasms. | Socratic